Search
Now showing items 1-10 of 194
New perspectives in iron chelation therapy for the treatment of Parkinson’s disease
(Wolters Kluwer, 2019)
Neurotoxins as Preclinical Models for Parkinson’s Disease
(Springer New York LLC, 2018)
© 2018, Springer Science+Business Media, LLC, part of Springer Nature.Translational medicine is one of the major concerns in this century. While significant advances have been made with scientific knowledge, the translation ...
Bell's phenomenon in normal adults and in Parkinson's disease
(1980)
Bell's phenomenon (upward and outward rolling of the eyeballs on forcible closure of the eyelids) was studied in normal adults and in patients suffering from Parkinson's disease. Advancing age correlates with diminution ...
An ERcentric view of Parkinson's disease
(2013)
Parkinson's disease (PD) is the second most common neurodegenerative disease and is characterized by the selective loss of dopaminergic neurons of the substantia nigra pars compacta and the accumulation of intracellular ...
An ERcentric view of Parkinson's disease
(Elsevier, 2013-03)
Parkinson's disease (PD) is the second most common neurodegenerative disease and is characterized by the selective loss of dopaminergic neurons of the substantia nigra pars compacta and the accumulation of intracellular ...
Hormesis: Protecting neurons against cellular stress in Parkinson disease
(Taylor and Francis Inc., 2012)
Protein folding stress is a salient feature of the most frequent neurodegenerative diseases. Although the accumulation of abnormally folded proteins is a well-characterized event underlying the pathology, the way cells ...
Targeting of the unfolded protein response (UPR) as therapy for Parkinson's disease
(Wiley-Blackwell Publishing Ltd, 2019)
Parkinson's disease is the second most common neurodegenerative disorder, leading to the progressive decline of motor control due to the loss of dopaminergic neurons in the substantia nigra pars compacta. At the molecular ...
ER proteostasis disturbances in Parkinson's disease: novel insights
(Frontiers Research Foundation, 2015)
ER proteostasis disturbances in Parkinson’s disease: novel insights
(Frontiers Media, 2015)